ProCE Banner Activity

Current and Emerging Biomarkers in Lung Cancer Therapy

Slideset Download
Download this slideset on established and emerging biomarkers critical to optimal use of targeted therapy and immunotherapy in patients with NSCLC.

Released: September 11, 2020

Expiration: September 10, 2021

No longer available for credit.

Share

Faculty

Matthew Gubens

Matthew Gubens, MD, MS

Associate Professor
Thoracic Oncology
University of California, San Francisco
San Francisco, California

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Amgen, Inc.

Merck Sharp & Dohme Corp.

Faculty Disclosure

Primary Author

Matthew Gubens, MD, MS

Associate Professor
Thoracic Oncology
University of California, San Francisco
San Francisco, California